市場調查報告書

全球電子藥物遞輸系統市場:各類型,用途,及地區預測

Global Electronic Drug Delivery Systems Market Size study, by Type, by Indication and Regional Forecasts 2019-2026

出版商 Bizwit Research & Consulting LLP 商品編碼 920260
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
全球電子藥物遞輸系統市場:各類型,用途,及地區預測 Global Electronic Drug Delivery Systems Market Size study, by Type, by Indication and Regional Forecasts 2019-2026
出版日期: 2019年12月15日內容資訊: 英文
簡介

本報告提供全球電子藥物遞輸系統市場的相關調查,提供市場機會和課題,成長要素,各類型·適應症·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

  • 市場概述
  • 主要趨勢
  • 市場估計及預測:世界/各市場區隔
    • 各類型
    • 各適應症
    • 各地區
  • 估計方法
  • 調查的前提條件

第2章 市場定義·範圍

  • 調查的目的
  • 市場定義·範圍
    • 產業的演進
    • 調查範圍
  • 研究涵蓋年份
  • 貨幣換算比率

第3章 市場動態

  • Seesaw分析
    • 市場成長要素
    • 市場課題
    • 市場機會

第4章 產業分析

  • 波特的五力分析
    • 買主談判力
    • 供應商談判力
    • 新加入廠商的威脅
    • 替代品的威脅
    • 產業內的競爭
    • 未來性方法
  • PEST分析
    • 政治方案
    • 經濟方案
    • 社會方案
    • 技術方案
  • 主要的購買標準(隨選)
  • 法律規範(隨選)
  • 投資/引進方案(隨選)
  • 分析師的建議·結論

第5章 市場分析:各類型

  • 市場概述
  • 市場實際成果:潛在力分析
  • 子區隔分析
    • 電子穿戴式輸液幫浦
    • 電子式自動注射器
    • 電子注射筆
    • 電子吸入器

第6章 市場分析:各適應症

  • 市場概述
  • 市場實際成果:潛在力分析
  • 子區隔分析
    • 糖尿病
    • 多發性硬化症
    • 循環系統疾病
    • 氣喘·COPD
    • 其他適應

第7章 市場分析:各地區

  • 市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 南美
    • 巴西
    • 墨西哥
  • 其他地區
    • 中東·非洲

第8章 競爭情形

  • 企業的市場佔有率(資料的可用性別)
  • 主要市場策略
  • 公司概要
    • Merck Group (德國)
    • Insulet Corporation (美國)
    • Bayer AG (德國)
    • Medtronic PLC (愛爾蘭)
    • Novo Nordisk (丹麥)
    • United Therapeutics Corporation (美國)
    • AstraZeneca (英國)
    • Tandem Diabetes Care (美國)
    • Amgen (美國)

第9章 調查方法

  • 調查方法
    • 資料探勘
    • 分析
    • 市場預測
    • 檢驗
    • 出版
    • 調查的前提條件
目錄

Global Electronic Drug Delivery Systems Market is valued approximately USD 7.2 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 8.7% over the forecast period 2019-2026. Drug delivery includes formulations, technologies, methods and systems for transferring an active pharmaceutical ingredient into the body. Electronic drug delivery systems are an advancement in the field which provides portable, interactive, wirelessly connected delivery systems and support patient administered therapy. The high prevalence of target diseases, the favorable reimbursement scenario in major markets, and advancements in technologies and designs of electronic drug delivery systems has increased the adoption of Electronic Drug Delivery Systems across the globe. However, the operation and functionality issues associated with the electronic devices will act as a restriction to the electronic drug delivery system market.

The regional analysis of global Electronic Drug Delivery Systems market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising prevalence of target diseases, the favorable reimbursement scenario, and approvals, and launches of innovative electronic drug delivery systems in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as increasing population along with increasing government expenditure on public health and research and development would create lucrative growth prospects for the Electronic Drug Delivery Systems market across Asia-Pacific region.

Major market player included in this report are:

Merck Group (Germany)

Insulet Corporation (US)

Bayer AG (Germany)

Medtronic PLC (Ireland)

Novo Nordisk (Denmark)

United Therapeutics Corporation (US)

Astrazeneca (UK)

Tandem Diabetes Care (US)

Amgen (US)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Electronic Wearable Infusion Pumps

Electronic Autoinjectors

Electronic Injection Pens

Electronic Inhalers

By Indication:

Diabetes

Multiple Sclerosis

Cardiovascular Disease

Asthma & COPD

Other Indications (growth hormone therapy, primary immunodeficiency disease, thalassemia, and Parkinson's disease)

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2016, 2017

Base year - 2018

Forecast period - 2019 to 2026

Target Audience of the Global Electronic Drug Delivery Systems Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investor

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Key Trends
  • 1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
    • 1.3.1. Electronic Drug Delivery Systems Market, by Type, 2016-2026 (USD Billion)
    • 1.3.2. Electronic Drug Delivery Systems Market, by Indication, 2016-2026 (USD Billion)
    • 1.3.3. Electronic Drug Delivery Systems Market, by Region, 2016-2026 (USD Billion)
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Electronic Drug Delivery Systems Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Electronic Drug Delivery Systems Market Dynamics

  • 3.1. See Saw Analysis
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Electronic Drug Delivery Systems Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Buyers
    • 4.1.2. Bargaining Power of Suppliers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.2. PEST Analysis
    • 4.2.1. Political Scenario
    • 4.2.2. Economic Scenario
    • 4.2.3. Social Scenario
    • 4.2.4. Technological Scenario
  • 4.3. Key Buying Criteria (On Demand)
  • 4.4. Regulatory Framework (On Demand)
  • 4.5. Investment Vs Adoption Scenario (On Demand)
  • 4.6. Analyst Recommendation & Conclusion

Chapter 5. Global Electronic Drug Delivery Systems Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Market Performance - Potential Model
  • 5.3. Electronic Drug Delivery Systems Market, Sub Segment Analysis
    • 5.3.1. Electronic Wearable Infusion Pumps
      • 5.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.3.2. Electronic Autoinjectors
      • 5.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.3.3. Electronic Injection Pens
      • 5.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.3.4. Electronic Inhalers
      • 5.3.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.3.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 6. Global Electronic Drug Delivery Systems Market, by Indication

  • 6.1. Market Snapshot
  • 6.2. Market Performance - Potential Model
  • 6.3. Electronic Drug Delivery Systems Market, Sub Segment Analysis
    • 6.3.1. Diabetes
      • 6.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.3.2. Multiple Sclerosis
      • 6.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.3.3. Cardiovascular Disease
      • 6.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.3.4. Asthma & COPD
      • 6.3.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.3.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.3.5. Other Indications
      • 6.3.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.3.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 7. Global Electronic Drug Delivery Systems Market, by Regional Analysis

  • 7.1. Electronic Drug Delivery Systems Market, Regional Market Snapshot (2016-2026)
  • 7.2. North America Electronic Drug Delivery Systems Market Snapshot
    • 7.2.1. U.S.
      • 7.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.2.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.2.1.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.2.2. Canada
      • 7.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.2.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.2.2.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 7.3. Europe Electronic Drug Delivery Systems Market Snapshot
    • 7.3.1. U.K.
      • 7.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.1.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.3.2. Germany
      • 7.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.2.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.3.3. Rest of Europe
      • 7.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.3.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.3.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 7.4. Asia Electronic Drug Delivery Systems Market Snapshot
    • 7.4.1. China
      • 7.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.1.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.2. India
      • 7.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.2.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.3. Japan
      • 7.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.3.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.3.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.4. Rest of Asia Pacific
      • 7.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.4.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.4.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 7.5. Latin America Electronic Drug Delivery Systems Market Snapshot
    • 7.5.1. Brazil
      • 7.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.5.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.5.1.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.5.2. Mexico
      • 7.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.5.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.5.2.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 7.6. Rest of The World
    • 7.6.1. Middle East and Africa
      • 7.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.6.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.6.1.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 8. Competitive Intelligence

  • 8.1. Company Market Share (Subject to Data Availability)
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Merck Group (Germany)
      • 8.3.1.1. Overview
      • 8.3.1.2. Financial (Subject to Data Availability)
      • 8.3.1.3. Product Summary
      • 8.3.1.4. Recent Developments
    • 8.3.2. Insulet Corporation (US)
    • 8.3.3. Bayer AG (Germany)
    • 8.3.4. Medtronic PLC (Ireland)
    • 8.3.5. Novo Nordisk (Denmark)
    • 8.3.6. United Therapeutics Corporation (US)
    • 8.3.7. AstraZeneca (UK)
    • 8.3.8. Tandem Diabetes Care (US)
    • 8.3.9. Amgen (US)

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
    • 9.1.6. Research Assumption

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET
  • TABLE 3. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY COMPOSITION 2016-2026 (USD BILLION)
  • TABLE 8. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD BILLION)
  • TABLE 9. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 10. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 11. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 21. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 22. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 23. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 24. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 25. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 26. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 27. U.S. ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 28. U.S. ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 29. U.S. ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 30. CANADA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 31. CANADA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 32. CANADA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 33. UK ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 34. UK ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 35. UK ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 36. GERMANY ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 37. GERMANY ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 38. GERMANY ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 39. ROE ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 40. ROE ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 41. ROE ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 42. CHINA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 43. CHINA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 44. CHINA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 45. INDIA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 46. INDIA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 47. INDIA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 48. JAPAN ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 49. JAPAN ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 50. JAPAN ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 51. ROAPAC ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 52. ROAPAC ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 53. ROAPAC ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 54. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 55. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 56. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 57. MEXICO ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 58. MEXICO ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 59. MEXICO ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 60. ROLA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 61. ROLA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 62. ROLA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 63. ROW ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 64. ROW ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 65. ROW ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

  • FIG 1. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, MARKET ESTIMATION INDICATIONS
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, KEY TRENDS 2017
  • FIG 5. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, GROWTH PROSPECTS 2018-2026
  • FIG 6. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 10. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 11. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 12. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 13. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 14. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 15. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 16. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 17. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 18. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 19. NORTH AMERICA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET 2016 & 2026 (USD BILLION)
  • FIG 20. EUROPE ELECTRONIC DRUG DELIVERY SYSTEMS MARKET 2016 & 2026 (USD BILLION)
  • FIG 21. ASIA PACIFIC ELECTRONIC DRUG DELIVERY SYSTEMS MARKET 2016 & 2026 (USD BILLION)
  • FIG 22. LATIN AMERICA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET 2016 & 2026 (USD BILLION)
  • FIG 23. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, COMPANY MARKET SHARE ANALYSIS (2016)
Back to Top